Veeva Systems Inc (N:VEEV)
Business Focus: Medical Software & Technology Services
| Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 4280 Hacienda Drive PLEASANTON CA 94588 |
| Tel: | 1-267-4605839 |
| Website: | https://www.veeva.com/medtech |
| IR: | See website |
| Key People | ||
| Thomas D. Schwenger President and Chief Customer Officer | E. Nitsa Zuppas President and Chief of Staff | Peter P. Gassner Chief Executive Officer, Director |
| Timothy S. Cabral Interim Chief Financial Officer, Director | Jonathan W. Faddis Senior Vice President, General Counsel, Corporate Secretary | Kristine B. Diamond Principal Accounting Officer | Stacey Epstein Chief Marketing Officer |
| Business Overview |
| Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Company's three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass. |
| Financial Overview |
| For the fiscal year ended 31 January 2024, Veeva Systems Inc revenues increased 10% to $2.36B. Net income increased 8% to $525.7M. Revenues reflect Subscription services- R&D Solutions segment increase of 15% to $905.8M, Subscription services- Commercial Solutions segment increase of 5% to $995.8M, North America segment increase of 11% to $1.39B, Europe segment increase of 11% to $662.6M. |
| Employees: | 7,172 as of Jan 31, 2024 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $28,859M as of Jan 31, 2024 |
| Annual revenue (TTM): | $2,364M as of Jan 31, 2024 |
| EBITDA (TTM): | $461.96M as of Jan 31, 2024 |
| Net annual income (TTM): | $525.71M as of Jan 31, 2024 |
| Free cash flow (TTM): | $885.14M as of Jan 31, 2024 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 161,381,384 as of Mar 29, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.